Statins' Role In Preventing Strokes: What We Know

Statins are 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors, which can lower blood lipid levels, improve endothelial function, inhibit inflammation, and stabilize atherosclerosis. Research has shown that statins can reduce the risk of many cardiovascular diseases, such as ischemic heart disease, hypercholesterolemia, and atherosclerotic cardiovascular diseases. However, the question of whether statins can be used to prevent strokes has been less clear. While some studies have indicated that statins have no significant effect on the mortality and morbidity of patients with strokes, others have found that they can reduce the risk of recurrence in patients who have already had a stroke.

Statins are associated with a lower risk of stroke in patients with atrial fibrillation

Atrial fibrillation is the most common heart rhythm disorder, affecting over 40 million people worldwide. Patients with the condition have a five times greater risk of stroke than their peers. While anticoagulant medication is recommended to prevent strokes in those with atrial fibrillation, it does not completely eliminate the risk. Statin therapy is widely prescribed to lower blood cholesterol and reduce the likelihood of heart attack and stroke. However, the benefit of statins for stroke prevention in patients with atrial fibrillation has been unclear.

The study, presented at the European Heart Rhythm Association (EHRA) 2023 meeting in Barcelona, Spain, evaluated the association between statin use and the incidence of stroke and transient ischaemic attack in patients with atrial fibrillation. The researchers identified all patients with a new diagnosis of atrial fibrillation between 2010 and 2018 and divided them into two groups: statin users and non-users. Statin users had received the medication for at least 90 consecutive days during the year after being diagnosed with atrial fibrillation.

The study found that statin users had a significantly lower risk of all primary outcomes compared to non-users. Specifically, statin use was associated with a 17% reduced risk of ischaemic stroke or systemic embolism, a 7% reduced risk of haemorrhagic stroke, and a 15% reduced risk of transient ischaemic attack. Long-term statin use was also found to be more protective than short-term use.

The findings suggest that statins can effectively reduce the risk of stroke in patients with atrial fibrillation, with long-term use offering greater protection.

Statins can be used in combination with other drugs to treat stroke patients

Statins are 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. They can lower blood lipid levels, improve endothelial function, inhibit inflammation, and stabilise atherosclerosis. They are also used to treat cardiovascular diseases such as ischemic heart disease, hypercholesterolemia, and atherosclerotic cardiovascular diseases.

Statins have been found to improve endothelial function, modulate thrombogenesis, attenuate inflammatory and oxidative stress damage, and facilitate angiogenesis beyond lowering cholesterol levels. They have also been proven to significantly decrease cardiovascular risk and improve clinical outcomes.

In recent years, there has been a vast expansion in the understanding of the pathophysiology of ischemic stroke and the pleiotropic effects of statins. Clinical trials involving statins for the prevention and treatment of ischemic stroke have commenced. Treatment with statins before or after a stroke has been proven to associate with reduced infarct volume and improved neurological function in animal models.

Several large clinical trials have established that statin use in ischemic stroke is associated with a reduced risk of incident and recurrent stroke. For example, the SPARCL trial showed that atorvastatin reduced the incidence of recurrent ischemic stroke versus placebo.

In conclusion, statins have pleiotropic beneficial effects in ischemic stroke and offer new opportunities for prevention and treatment. They should be considered a crucial medicine in ischemic stroke prevention and therapy.

Statins may need to be used with other drugs to prevent strokes

Statins are 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors. They work by lowering blood lipid levels, improving endothelial function, inhibiting inflammation, and stabilising atherosclerosis. Research has shown that statins can reduce the risk of many cardiovascular issues, such as ischemic heart disease, hypercholesterolemia, and atherosclerotic cardiovascular disease.

Statins have been shown to be effective in reducing the risk of stroke recurrence by 12-16% in patients with ischemic stroke or TIA (transient ischemic attack) of presumed atherosclerotic origin or with other comorbid atherosclerotic cardiovascular disease. However, there is limited evidence that statins on their own can reduce the risk of stroke mortality, incidence, and morbidity.

A region-wide study in Hong Kong, China, found that statin use was associated with a reduced risk of stroke in patients with atrial fibrillation. The study, which included over 50,000 patients, showed that long-term statin use was even more protective against stroke than short-term use.

While statins have been shown to be beneficial in preventing stroke recurrence, their effectiveness in preventing initial strokes is less clear. Some studies suggest that statins may need to be used in combination with other drugs to prevent strokes effectively. For example, Zhang et al. found that the combination of atorvastatin and other drugs in a rat model reduced the incidence of hemorrhagic stroke. Similarly, Lu et al. demonstrated that the combination of rosuvastatin and other drugs after a stroke helped prevent the stroke from turning into a hemorrhagic stroke.

Therefore, while statins have a role in preventing stroke recurrence, their effectiveness in preventing initial strokes may be enhanced when used in conjunction with other drugs or treatments.

Statins can reduce the risk of many cardiovascular diseases

Statins have been shown to improve myocardial infarction and stroke by reducing serum cholesterol levels. They can also be used in combination with other drugs to treat patients who have had a stroke. For instance, atorvastatin has been shown to reduce the incidence of stroke when used in combination with other drugs. In addition, rosuvastatin has been found to prevent strokes from turning into hemorrhagic strokes when used after the stroke has occurred.

Statins are now recommended for the primary prevention of ischemic stroke in patients with a high 10-year risk for cardiovascular events. They reduce the risk of stroke recurrence by 12-16% and are recommended for patients with ischemic stroke or transient ischaemic attack (TIA) presumed to be of atherosclerotic origin or with other comorbid atherosclerotic cardiovascular disease.

A region-wide study in over 50,000 patients with atrial fibrillation found reduced risks of stroke and transient ischaemic attack in those who started statins within a year of diagnosis compared with those who did not. Long-term statin use was associated with greater protection than short-term use. Compared to those taking the medication for between three months and two years, patients using statins for six years or longer had a 43% lower risk of ischaemic stroke or systemic embolism, a 44% reduced likelihood of haemorrhagic stroke, and a 42% reduced risk of transient ischaemic attack.

Statins can lower blood lipid levels

Statins lower 'bad' LDL cholesterol levels and increase 'good' HDL cholesterol levels. LDL (low-density lipoprotein) cholesterol is called 'bad' because it blocks the good HDL and contributes to plaque buildup in the artery walls. This buildup of plaque in the arteries is known as atherosclerosis, which can lead to a heart attack or stroke. HDL (high-density lipoprotein) cholesterol, on the other hand, moves extra cholesterol in the bloodstream to the liver, which dispenses it from the body.

Statins can lower LDL cholesterol by 50% or more and are some of the most common prescriptions in America, with over 92 million adults taking them. They are particularly beneficial for those who cannot bring their cholesterol into a normal range through diet and exercise alone.

In addition to lowering cholesterol, statins also have anti-inflammatory and antioxidant effects, which can further reduce the risk of cardiovascular events such as stroke.

Frequently asked questions